This company is no longer active
MO4 Stock Overview
Mediclinic International plc, together with its subsidiaries, operates private hospitals.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Mediclinic International plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£5.72 |
| 52 Week High | UK£5.95 |
| 52 Week Low | UK£4.44 |
| Beta | 0.42 |
| 1 Month Change | 2.33% |
| 3 Month Change | 1.24% |
| 1 Year Change | 28.83% |
| 3 Year Change | 81.13% |
| 5 Year Change | -16.13% |
| Change since IPO | -50.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| MO4 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.3% | 4.1% | -1.5% |
| 1Y | 28.8% | -0.8% | 0.9% |
Return vs Industry: MO4 exceeded the German Healthcare industry which returned -21.5% over the past year.
Return vs Market: MO4 exceeded the German Market which returned -8.5% over the past year.
Price Volatility
| MO4 volatility | |
|---|---|
| MO4 Average Weekly Movement | 1.7% |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: MO4 has not had significant price volatility in the past 3 months.
Volatility Over Time: MO4's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 33,683 | Ronnie van der Merwe | www.mediclinic.com |
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom.
Mediclinic International plc Fundamentals Summary
| MO4 fundamental statistics | |
|---|---|
| Market cap | €4.26b |
| Earnings (TTM) | €194.98m |
| Revenue (TTM) | €3.90b |
21.9x
P/E Ratio1.1x
P/S RatioIs MO4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MO4 income statement (TTM) | |
|---|---|
| Revenue | UK£3.38b |
| Cost of Revenue | UK£2.66b |
| Gross Profit | UK£728.00m |
| Other Expenses | UK£559.00m |
| Earnings | UK£169.00m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 21.52% |
| Net Profit Margin | 5.00% |
| Debt/Equity Ratio | 54.1% |
How did MO4 perform over the long term?
See historical performance and comparison